M
190.00
-2.00 (-1.04%)
| 前收盘价格 | 192.00 |
| 收盘价格 | 194.40 |
| 成交量 | 30,313 |
| 平均成交量 (3个月) | 36,816 |
| 市值 | 201,996,592 |
| 价格/销量 (P/S) | 7.57 |
| 股市价格/股市净资产 (P/B) | 1.43 |
| 52周波幅 | |
| 利润日期 | 7 May 2025 |
| 营业毛利率 | -106.29% |
| 营业利益率 (TTM) | -148.41% |
| 稀释每股收益 (EPS TTM) | -0.290 |
| 季度收入增长率 (YOY) | -44.50% |
| 总债务/股东权益 (D/E MRQ) | 8.74% |
| 流动比率 (MRQ) | 10.88 |
| 营业现金流 (OCF TTM) | -27.61 M |
| 杠杆自由现金流 (LFCF TTM) | -13.72 M |
| 资产报酬率 (ROA TTM) | -12.60% |
| 股东权益报酬率 (ROE TTM) | -18.73% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (GB) | 混合的 | 混合的 |
| Medical Devices (全球的) | 看跌 | 混合的 | |
| 股票 | MAXCYTE INC COM STK USD0.01 (DI | - | - |
AIStockmoo 评分
1.4
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 3.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.38 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| MAXCYTE INC COM STK USD0.01 (DI | 202 M | - | - | 1.43 |
| 0K5E | 765 M | 4.01% | 7.06 | - |
| CREO MEDICAL GROUP PLC ORD GBP0 | 44 M | - | - | 1.57 |
| INTELLIGENT ULTRASOUND GROUP PL | 36 M | - | - | 7.29 |
| NOVACYT S.A. EUR1/15TH (CDI) | 34 M | - | - | 0.710 |
| INSPIRATION HEALTHCARE GROUP PL | 15 M | - | - | 0.550 |
|
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 1.56% |
| 机构持股比例 | 74.58% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合